Dimethyl Fumarate as Therapeutic Alternative in Moderate-to-Severe Psoriasis: Our Experience

PURPOSE: Dimethyl fumarate (DMF) is an oral formulation approved for the treatment of moderate-to-severe psoriasis in adult patients requiring systemic therapy. Here, we describe our clinical experience with DMF for moderate-to-severe psoriasis in Spain. PATIENTS AND METHODS: This is a retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosés Gibert, Pau, de la Torre Gomar, Francisco Javier, Saenz Aguirre, Amaia, Gimeno Castillo, Javier, González Pérez, Ricardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250788/
https://www.ncbi.nlm.nih.gov/pubmed/35791415
http://dx.doi.org/10.2147/PTT.S367060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250788/
https://www.ncbi.nlm.nih.gov/pubmed/35791415
http://dx.doi.org/10.2147/PTT.S367060

Ejemplares similares